Canterbury v. Boston Scientific Corporation
Filing
425
MEMORANDUM OPINION AND ORDER (Defendant's Motion for Partial Summary Judgment on Plaintiffs' Punitive Damages Claims and Plaintiff's Motion for Leave to Amend Complaint) for the reasons explained herein, denying 263 MOTION by Boston Scientific Corporation for Partial Summary Judgment on Plaintiffs' Punitive Damages Claims and denying 167 MOTION by Chris Rene Wilson for Leave to Amend Complaint. Directing the Clerk to post a copy of this published opinion on the court's website, www.wvsd.uscourts.gov. Signed by Judge Joseph R. Goodwin on 10/9/2014. (cc: attys; any unrepresented party) (skh)
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA
CHARLESTON DIVISION
Tammy Hendricks, et al.,
Plaintiffs,
v.
Lead Civil Action No. 2:12-cv-08633
Boston Scientific Corporation,
Defendant.
MEMORANDUM OPINION AND ORDER
(Defendant’s Motion for Partial Summary Judgment on Plaintiffs’ Punitive Damages
Claims and Plaintiff’s Motion for Leave to Amend Complaint)
Pending before the court are (1) Boston Scientific Corporation’s (“BSC”) Motion for
Partial Summary Judgment on Plaintiffs’ Punitive Damages Claims [Docket 263];1 and (2)
plaintiff Chris Rene Wilson’s Motion for Leave to Amend the Complaint [Docket 167]. For the
reasons below, I FIND that West Virginia law, not Massachusetts law, applies to plaintiffs’
punitive damages claims and that there are genuine disputes of material fact over whether
punitive damages are appropriate. Accordingly, I DENY BSC’s Motion for Partial Summary
Judgment on Plaintiffs’ Punitive Damages Claims. Because I conclude West Virginia punitive
damages law applies here and Ms. Wilson concedes her motion is moot if this is so, I DENY
plaintiff Chris Rene Wilson’s Motion for Leave to Amend the Complaint.
1
All plaintiffs to whom this motion relates, including Chris Rene Wilson, were implanted with the Obtryx device in
West Virginia. (See BSC’s Mem. of Law in Supp. of Mot. for Partial Summ. J. on Pls.’ Pun. Dam. Claims [Docket
264] (“Def.’s Mem.”) ¶¶ 6–31).
I.
Background
Plaintiffs’ cases are seven of more than 60,000 assigned to me by the Judicial Panel on
Multidistrict Litigation in seven different MDLs against various manufacturers. Of the more than
60,000 cases, over 13,000 reside in the Boston Scientific MDL.2 These cases involve the use of
transvaginal surgical mesh to treat pelvic organ prolapse and stress urinary incontinence. In this
particular case, plaintiffs, including Ms. Wilson, were implanted with a product manufactured by
defendant Boston Scientific Corporation (“BSC”): the Obtryx Transobturator Mid-Urethral Sling
System (“Obtryx”). The plaintiffs allege that as a result of implantation with this product they
experienced several complications. The plaintiffs currently advance the following claims:
negligence, strict liability (defective design, manufacturing defect, and failure to warn), breach of
express and implied warranties, fraudulent concealment, and punitive damages.3 (See, e.g.,
Wilson Short Form Compl. [Docket 1] ¶ 13).
On July 9, 2014, Ms. Wilson moved the court for leave to amend her complaint so she
could add a claim for damages (including punitive) under Massachusetts law. On August 1,
2014, BSC moved for partial summary judgment on plaintiffs’ punitive damages claims. In
September 2014 the court requested supplemental briefing on choice-of-law issues pertaining to
both motions. Having reviewed the briefs and arguments of the parties, I address the defendant’s
motion first.
II.
Legal Standard
To obtain summary judgment, the moving party must show that there is no genuine issue
as to any material fact and that the moving party is entitled to judgment as a matter of law. Fed.
2
By Pretrial Order # 78, dated February 19, 2014, I originally consolidated eleven cases for trial. Of the original
eleven, seven remain pending. (See Pretrial Order # 78 [Docket 9]). Of the seven pending, three (Ms. Pugh, Ms.
Hendricks and Ms. Moore) recently filed stipulations of dismissal with prejudice, leaving four plaintiffs.
3
One of the remaining plaintiffs (Ms. Tyree) alleges loss of consortium.
2
R. Civ. P. 56(a). In considering a motion for summary judgment, the court will not “weigh the
evidence and determine the truth of the matter.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242,
249 (1986). Instead, the court will draw any permissible inference from the underlying facts in
the light most favorable to the nonmoving party. Matsushita Elec. Indus. Co. v. Zenith Radio
Corp., 475 U.S. 574 587–88 (1986).
Although the court will view all underlying facts and inferences in the light most
favorable to the nonmoving party, the nonmoving party nonetheless must offer some “concrete
evidence from which a reasonable juror could return a verdict in his [or her] favor.” Anderson,
477 U.S. at 256. Summary judgment is appropriate when the nonmoving party has the burden of
proof on an essential element of his or her case and does not make, after adequate time for
discovery, a showing sufficient to establish that element. Celotex Corp. v. Catrett, 477 U.S. 317,
322–23 (1986). The nonmoving party must satisfy this burden of proof by offering more than a
mere “scintilla of evidence” in support of his or her position. Anderson, 477 U.S. at 252.
Likewise, conclusory allegations or unsupported speculation, without more, are insufficient to
preclude the granting of a summary judgment motion. See Felty v. Graves–Humphreys Co., 818
F.2d 1126, 1128 (4th Cir. 1987); Ross v. Commc’ns Satellite Corp., 759 F.2d 355, 365 (4th Cir.
1985), abrogated on other grounds, Price Waterhouse v. Hopkins, 490 U.S. 228 (1989).
III.
Discussion
Plaintiffs and the defendant do not dispute that West Virginia’s choice-of-law principles
apply here. (See Def.’s Mem. in Supp. of Mot. Part. Summ. J. on Pls.’ Pun. Dam. Claims
[Docket 264] (“Def.’s Mem.”), at 7; Pls.’ Resp. in Opp. to Boston Scientific Corporation’s Mot.
Part. Summ. J. on Pls.’ Pun. Dam. Claims [Docket 287] (“Pls.’ Resp.”), at 9–10). Nor do the
parties dispute that West Virginia law applies to plaintiffs’ claims for compensatory damages.
3
The defendant, however, contends that West Virginia’s choice-of-law principles dictate
application of Massachusetts substantive law to plaintiffs’ punitive damages claims. (See Def.’s
Mem. at 8–10). By contrast, plaintiffs maintain that West Virginia law controls this issue. (See
Pls.’ Resp. at 9–16).
A. West Virginia Follows the Lex Loci Delicti Rule for Torts
I turn first to West Virginia’s choice-of-law principles. With respect to causes of action
sounding in tort, West Virginia follows the traditional rule that the applicable substantive law is
the law of the place of injury. West Virginia ex rel. Chemtall, Inc. v. Madden, 607 S.E.2d 772,
779–80 (W. Va. 2004); McKinney v. Fairchild Intern., Inc., 487 S.E.2d 913, 922 (W. Va. 1997)
(“Traditionally, West Virginia courts apply the lex loci delicti choice-of-law rule; that is, the
substantive rights between the parties are determined by the law of the place of injury.”); Paul v.
Nat’l Life, 352 S.E.2d 550, 555, 555 n.13 (W. Va. 1986) (noting that “[l]ex loci delicti has long
been the cornerstone of our conflict of laws doctrine” and collecting cases).
It is true that on a handful of occasions the Supreme Court of Appeals of West Virginia
has invoked the most-significant-relationship test in the tort context. See, e.g., Oakes v. Oxygen
Therapy Servs., 363 S.E.2d 130, 131 (W. Va. 1987) (noting that the court has used the mostsignificant-relationship test to resolve “particularly thorny conflicts problems”). However, such
circumstances have arisen in “cases involving complex, or unusual, contractual situations and
torts which very existence are dependent upon the brea[d]th and legality of contracts.” Ball v.
Joy Mfg. Co., 755 F. Supp. 1344, 1351 (S.D. W. Va. 1990) (emphasis added) (citing Lee v.
Saliga, 373 S.E.2d 345, 350–52 (W. Va. 1988); Oakes, 363 S.E.2d at 131; New v. Tac & C
Energy, Inc., 355 S.E.2d 629 (W. Va. 1987); General Elec. Co. v. Keyser, 275 S.E.2d 289 (W.
Va. 1981)).
4
In Oakes, for example, the complexity that triggered the most-significant-relationship test
arose from “the relationship between the Maryland [employment] contract and appellant’s tort
theory.” 363 S.E.2d at 132 (emphases added). The Oakes court faced a peculiar dilemma. On the
one hand, if the court characterized plaintiff’s claim purely as one of contract, it would likely
conclude under West Virginia’s conflicts principles that Maryland law applied because Maryland
was the place of contracting and the document contained a choice-of-law provision selecting
Maryland law. See id. (“The plaintiff was employed . . . under an employment contract signed by
the parties in Maryland that specified that Maryland law should apply to all matters arising under
the contract.”). On the other hand, if the court characterized plaintiff’s claim as one of tort, it
might conclude that West Virginia law applied because the plaintiff was physically present in
West Virginia when he was discharged, that is, plaintiff felt his injury in West Virginia. See id.
(noting that the decision to terminate the plaintiff occurred in Maryland “while [plaintiff] was
hospitalized in West Virginia”). Rather than rigidly apply traditional contract or lex loci delicti
choice-of-law principles, the court reasoned that the facts were “sufficiently complex because of
the relationship between the Maryland contract and appellant’s tort theory that the Restatement
standards,” which include the most-significant-relationship test, “provide useful guidance.” Id.
Similarly, in Lee v. Saliga, the Supreme Court of Appeals noted that “[t]here is in any
uninsured motorist case a related tort aspect.” 373 S.E.2d 345, 348 (W. Va. 1988). But the
court’s invocation of the most-significant-relationship test was not explicitly premised on the
interplay between the tort and contract issues. Instead, the court reached the narrow conclusion
that “where in a suit for the recovery of uninsured motorist insurance benefits an issue arises
which involves insurance coverage, that issue is to be resolved under conflict of laws principles
applicable to contracts.” 373 S.E.2d 345, 349 (W. Va. 1988) (footnote omitted); id. at 350
5
(“Having concluded that the issue presented is one of contract, we turn to a discussion of the
appropriate conflicts rule.”). In short, it appears that the contractual nature of the claim, rather
than a finding of a particularly thorny conflicts problem involving aspects of contract and tort,
triggered the most-significant-relationship test. The court announced a narrow rule to address the
specific circumstances before it:
[W]e find that the Restatement standard and its commentary provide useful
guidance along with our earlier cases in fashioning the following rule: The
provisions of a motor vehicle liability policy will ordinarily be construed
according to the laws of the state where the policy was issued and the risk insured
was principally located, unless another state has a more significant relationship to
the transaction and the parties.
Id. at 352–53 (footnote omitted).
Here, the defendant, headquartered in Massachusetts, sells products in many states across
the country. The defendant has not contracted with the plaintiffs in the sense an employer
contracts with employees or an insurer contracts with motorists. In fact, there are no complex or
unusual contractual wrinkles between the defendant and plaintiffs that bear significantly on the
underlying product-liability claims regarding pelvic mesh. Rather than implicating aspects of tort
and contract, these are “clear-cut cases of physical injury,” to which “the lex loci delicti rule has
generally been applied [in West Virginia].” Oakes, 363 S.E.2d at 131.
Stated simply, the plaintiffs were implanted with and allegedly injured by the defendant’s
product in West Virginia. There is no reason to depart from West Virginia’s traditional conflicts
principles and I FIND that West Virginia law applies to plaintiffs’ punitive damages claims. Cf.
In re C.R. Bard, Inc., MDL No. 2187, 2013 WL 2432871, at *2–3 (S.D. W. Va. June 4, 2013)
(“Under Georgia law, the traditional lex loci delicti rule generally applies to tort actions. . . .
With respect to the Cissons, the surgery to implant Ms. Cisson’s [pelvic mesh] product was
performed in Georgia and any alleged injuries occurred in Georgia. Accordingly, Georgia law
6
applies to [the punitive damages claim in] the Cisson case.”). “Certainly, a West Virginia court
has an interest in protecting its citizens from tortious conduct and is not precluded from doing so
simply because some of the tortious conduct occurred in another state.” Boyd v. Goffoli, 608
S.E.2d 169, 179 (W. Va. 2004) (finding constitutional application of West Virginia punitive
damages law when “Pennsylvania scheme” harmed West Virginia residents).
B. Analysis under West Virginia’s Punitive Damages Law
Having found that West Virginia law applies to plaintiffs’ punitive damages claims, I
now examine whether the plaintiffs have proffered sufficient evidence to survive summary
judgment. I find that they have. In West Virginia, the “law has long required more than a
showing of simple negligence to recover punitive damages.” Bennett v. 3 C Coal Co., 379 S.E.2d
388, 394 (W. Va. 1989). Punitive damages are appropriate against a defendant “[i]n actions of
tort, where gross fraud, malice, oppression, or wanton, willful, or reckless conduct or criminal
indifference to civil obligations affecting the rights of others appear.” Vandevender v. Sheetz,
Inc., 490 S.E.2d 678, 688 (W. Va. 1997); see also Syllabus Point 12, Marsch v. Am. Elec. Power
Co., 530 S.E.2d 173, 177 (W. Va. 1999) (noting that punitive damages serve as “punishment for
[the defendant’s] wilfulness, wantonness, malice, or other like aggravation of his wrong to the
plaintiff, over and above full compensation for all injuries directly or indirectly resulting from
such wrong.” (internal quotation marks and citations omitted)).
Plaintiffs assert that BSC engaged in wanton, willful, or reckless conduct with regard to
the claims alleged by plaintiffs related to the Obtryx. (See Pls.’ Resp. at 19). The question then,
on summary judgment, is whether plaintiffs’ allegations raise any genuine factual disputes. This
court recently resolved a similar issue under California law in favor of the plaintiffs. See Sanchez
v. Boston Scientific Corp., 2014 WL 4059214, No. 2:12-cv-05762, at *12-13 (S.D. W. Va. Aug.
7
18, 2014) (concluding on comparable evidence “there is a genuine dispute of material fact
whether BSC’s actions with respect to the Pinnacle device were malicious under California Civil
Code § 3294”). The court’s analysis in Sanchez applies, mutatis mutandis, to the present claims
regarding the Obtryx device.
Here, plaintiffs argue that BSC was aware that the polypropylene used to construct the
Obtryx device was not intended to be implanted in the human body. (See Pls.’ Resp. at 17). The
plaintiffs point to a material data safety sheet (“MSDS”) issued by BSC’s supplier of
polypropylene that warned BSC not to implant the material in the human body. The Obtryx
device is constructed using a polypropylene resin supplied by Chevron Phillips Chemical
Company LP. Chevron Phillips authored the MSDS that accompanied the resin. The MSDS
included the following warning:
MEDICAL APPLICATION CAUTION: Do not use this Chevron Phillips
Chemical Company LP material in medical applications involving permanent
implantation in the human body or permanent contact with internal body fluids or
tissues.
(MSDS [Docket 287-4], at 1). Despite this warning, BSC used Chevron Phillips polypropylene
in its Obtryx devices.
Additionally, the plaintiffs argue that BSC knew it needed to conduct long-term safety
studies of the polypropylene material in the Obtryx device. The plaintiffs point to the written
agreement between BSC and its polypropylene supplier (“the Agreement”). The Agreement
cautioned BSC to make its own determination of the safety and suitability of the polypropylene
material in BSC’s products. The agreement stated:
BOSTON SCIENTIFIC IS ADVISED AND CAUTIONED TO MAKE ITS
OWN DETERMINATION AND ASSESSMENT OF THE SAFETY AND
SUITABILITY OF THE . . . POLYPROPYLENE PRODUCT FOR USE BY,
FOR OR ON BEHALF OF BOSTON SCIENTIFIC. IT IS THE ULTIMATE
RESPONSIBILITY OF BOSTON SCIENTIFIC TO ENSURE THAT
8
THE . . . POLYPROPYLENE PRODUCT
SCIENTIFIC’S SPECIFIC APPLICATION.
IS
SUITED
TO
BOSTON
(Agreement [Docket 287-6], at 3–4)4.
Despite the MSDS warning and the admonition from BSC’s polypropylene supplier to
conduct its own tests, an internal BSC document indicated that BSC sponsored no clinical
studies on the Obtryx device. (See Obtryx Clinical Risk/Benefit Analysis [Docket 287-1] at 65).
In light of this evidence, I FIND that there is a genuine dispute of material fact whether
BSC’s actions with respect to the Obtryx device warrant an award of punitive damages. A
reasonable jury could find that by ignoring a warning on the MSDS and failing to conduct
clinical testing, BSC’s actions were wanton, willful, or reckless under West Virginia punitive
damages law. Cf. Davis v. Celotex Corp., 420 S.E.2d 557, 561 (W. Va. 1992) (“[W]e conclude
that when an asbestos manufacturer has actual or constructive knowledge of the severe health
hazards caused by a product and continues to manufacture and distribute that product, the
manufacturer may be found liable for punitive damages to those injured by the product.”).
Accordingly, BSC’s Motion for Partial Summary Judgment on Plaintiffs’ Punitive Damages
Claims is DENIED.
C. Ms. Wilson’s Motion for Leave to Amend the Complaint
I now turn to Ms. Wilson’s Motion for Leave to Amend the Complaint. She makes clear
in supplemental briefing that “[t]he need to amend Plaintiffs’ complaints would be rendered
moot if the Court denies BSC’s [motion].”6 (Pls.’ Suppl. Br. in Supp. of Pls.’ Mot. for Leave to
Amend Compl. [Docket 406], at 1). She acknowledges that should “the Court conclude[]
that . . . West Virginia punitive law applies, . . . Plaintiffs’ need to pursue their claims under
4
Pagination here is the court-stamped page number at the top of the exhibit pages.
Pagination here is the court-stamped page number at the top of the exhibit pages.
6
Ms. Wilson’s Motion is one of many motions to amend the complaint pending before the court in a number of
individual cases.
5
9
Massachusetts law would be rendered moot.” (Id. at 2). Having concluded that West Virginia
punitive damages law applies here, I DENY Ms. Wilson’s motion as moot.
IV.
Conclusion
For the reasons explained above, Boston Scientific Corporation’s Motion for Partial
Summary Judgment on Plaintiffs’ Punitive Damages Claims [Docket 263] is DENIED and Ms.
Wilson’s Motion for Leave to Amend the Complaint [Docket 167] is DENIED.
The court DIRECTS the Clerk to send a copy of this Order to counsel of record and any
unrepresented party. The court further DIRECTS the Clerk to post a copy of this published
opinion on the court’s website, www.wvsd.uscourts.gov.
ENTER: October 9, 2014
10
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?